Joincare Pharmaceutical Group Industry Co (XSWX:JCARE) Net Income (Continuing Operations): $395 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:JCARE Joincare Pharmaceutical Group Industry Co Ltd XSWX:JCARE
80 GF Score
Price $8.00
GF Value $9.20
! 3 Warning Signs
View Full Analysis

What is Joincare Pharmaceutical Group Industry Co Net Income (Continuing Operations)?

Joincare Pharmaceutical Group Industry Co XSWX:JCARE 80 Net Income (Continuing Operations) is $395 Mil as of Mar. 2026. GuruFocus rates XSWX:JCARE with a GF Score™ of 80/100 and a GF Value™ of $9.20. The stock has 3 warning signs investors should review.

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Joincare Pharmaceutical Group Industry Co's Net Income (Continuing Operations) for the three months ended in Mar. 2026 was $128 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2026 was $395 Mil.

Joincare Pharmaceutical Group Industry Co  (XSWX:JCARE) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Joincare Pharmaceutical Group Industry Co Net Income (Continuing Operations) Related Terms

Joincare Pharmaceutical Group Industry Co Net Income (Continuing Operations) Historical Data

* Premium members only.

The historical data trend for Joincare Pharmaceutical Group Industry Co's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Joincare Pharmaceutical Group Industry Co Net Income (Continuing Operations) Chart

Joincare Pharmaceutical Group Industry Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 410.23 415.15 399.29 409.68 406.78

Joincare Pharmaceutical Group Industry Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 132.58 111.78 95.58 59.70 128.18
XSWX:JCARE
80GF Score
Joincare Pharmaceutical Group Industry Co Ltd XSWX:JCARE
Net Income (Continuing Operations) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Joincare Pharmaceutical Group Industry Co Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $395 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Income (Continuing Operations) of $395 Mil mean?
Joincare Pharmaceutical Group Industry Co (XSWX:JCARE) has a Net Income (Continuing Operations) of $395 Mil as of Mar. 2026. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Joincare Pharmaceutical Group Industry Co and its competitors.
Is Joincare Pharmaceutical Group Industry Co's Net Income (Continuing Operations) too high?
Joincare Pharmaceutical Group Industry Co's current Net Income (Continuing Operations) is $395 Mil. Overall, Joincare Pharmaceutical Group Industry Co has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Joincare Pharmaceutical Group Industry Co's Net Income (Continuing Operations) compare to ZTS?
Joincare Pharmaceutical Group Industry Co's Net Income (Continuing Operations) of $395 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income (Continuing Operations) for a Drug Manufacturers company?
A good Net Income (Continuing Operations) depends on the Drug Manufacturers industry context. However, Net Income (Continuing Operations) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income (Continuing Operations) mean?
A high Net Income (Continuing Operations) can signal that a stock is expensive relative to its fundamentals. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Joincare Pharmaceutical Group Industry Co and its competitors. Joincare Pharmaceutical Group Industry Co's current Net Income (Continuing Operations) is $395 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Joincare Pharmaceutical Group Industry Co stock overvalued right now?
Joincare Pharmaceutical Group Industry Co (XSWX:JCARE) has a current Net Income (Continuing Operations) of $395 Mil. The stock's GF Value™ is $9.20, compared to a current price of $8.00 — trading 13% below its estimated fair value. The current Net Income (Continuing Operations) is $395 Mil. Joincare Pharmaceutical Group Industry Co's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income (Continuing Operations) calculated?
Net Income (Continuing Operations) is calculated from a company's financial statements. For Joincare Pharmaceutical Group Industry Co (XSWX:JCARE), the current Net Income (Continuing Operations) is $395 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Joincare Pharmaceutical Group Industry Co (XSWX:JCARE) Overvalued in 2026?

Based on GuruFocus' analysis, Joincare Pharmaceutical Group Industry Co stock appears to be undervalued. The current stock price of $8.00 is trading 13% below its estimated GF Value™ of $9.20.

Key valuation signals for XSWX:JCARE:

  • Net Income (Continuing Operations): $395 Mil
  • GF Value™: $9.20 vs. price of $8.00 (13% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the XSWX:JCARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Joincare Pharmaceutical Group Industry Co Business Description

Other Exchanges 600380:China
Address No. 17, Langshan Road, North District, High-tech Zone, Nanshan District, Guangdong, Shenzhen, CHN, 518057
Joincare Pharmaceutical Group Industry Co Ltd is an integrated pharmaceutical company, the business scope covers healthcare products, APIs, final dosage forms, prescription drugs, OTCs, Chinese traditional medicine, chemical drugs, and testing agents. APIs are antibiotic series and their intermediates 7ACA, 4AA and F9. Prescription drugs focus on the realms of the digestive tract, a blood vessel of heart and brain, infection, tumor, nervous cerebrovascular section, urinary system etc. OTCs include gastrointestinal drug Dele-Livzon, Live Bifidobacterium Preparation, oral ulcer drugs Yiketie, cold medicine Antiviral Oral Granule, External use skin medicine.
80GF Score

Get the complete analysis for XSWX:JCARE

Net Income (Continuing Operations) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.00
Price
$9.20
GF Value